Vitrolife AB Stock Nasdaq Stockholm
Stocks
SE0000816043
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 12.57B 1.27B 1.11B 1.05B 956M 1.79B 122B 1.79B 4.85B 62.24B 4.79B 4.68B 201B | P/E 2026 * |
25.5x | P/E 2027 * | 20.6x |
|---|---|---|---|---|---|
| Enterprise Value | 13.12B 1.33B 1.16B 1.09B 997M 1.87B 127B 1.87B 5.06B 64.96B 5B 4.89B 209B | EV / Sales 2026 * |
3.79x | EV / Sales 2027 * | 3.38x |
| Free-Float |
54.39% | Yield 2026 * |
1.19% | Yield 2027 * | 1.36% |
Last Transcript: Vitrolife AB
| 1 day | -0.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Bronwyn O'Connor
CEO | Chief Executive Officer | 52 | 01/08/2023 |
Pär Ihrskog
DFI | Director of Finance/CFO | 55 | 10/10/2025 |
Nicklas Hansen
CIO | Chief Investment Officer | 40 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Pia Marions
BRD | Director/Board Member | 63 | 19/04/2013 |
| Chairman | 70 | 01/08/2023 | |
| Chairman | 55 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.18% | -6.68% | - | - | 1.27B | ||
| -0.43% | +1.00% | +195.80% | +572.70% | 23.77B | ||
| -3.22% | +9.67% | +538.15% | +93.41% | 10.51B | ||
| +1.71% | +2.83% | -34.76% | -17.79% | 9.86B | ||
| -0.27% | +12.73% | -0.93% | - | 8.89B | ||
| -0.04% | -0.54% | +92.09% | +54.75% | 6.53B | ||
| +0.86% | +1.06% | -26.84% | -20.16% | 5.8B | ||
| +1.86% | +3.08% | -0.33% | -9.77% | 4.31B | ||
| +0.89% | +8.41% | +66.45% | +71.51% | 4.03B | ||
| +7.53% | +10.21% | -12.27% | -25.05% | 2.98B | ||
| Average | +0.92% | +4.50% | +90.82% | +89.95% | 8.52B | |
| Weighted average by Cap. | +0.19% | +3.65% | +138.68% | +218.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.46B 351M 307M 288M 263M 493M 33.53B 494M 1.33B 17.12B 1.32B 1.29B 55.2B | 3.71B 376M 329M 309M 282M 529M 35.95B 529M 1.43B 18.36B 1.41B 1.38B 59.19B |
| Net income | 493M 49.96M 43.66M 41.04M 37.45M 70.28M 4.78B 70.3M 190M 2.44B 188M 184M 7.86B | 609M 61.75M 53.97M 50.72M 46.29M 86.87M 5.9B 86.89M 235M 3.01B 232M 227M 9.72B |
| Net Debt | 549M 55.7M 48.67M 45.75M 41.75M 78.35M 5.32B 78.37M 212M 2.72B 209M 205M 8.77B | -26.74M -2.71M -2.37M -2.23M -2.03M -3.82M -259M -3.82M -10.32M -132M -10.19M -9.96M -427M |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















